Oral forms of meloxicam are frequently prescribed for treatment of pain in cats after surgical operations. Cats, however, are famously difficult objects for oral administration, this difficulty not lessened by pain, nausea, stress and other discomfort cats experience after operation and anaesthesia.
We are developing a subcutaneously injectable meloxicam hydrogel ST15C with a release time of 3 to 5 days to be administered by a vet just before or after an operation. Like in the case of ST14D the project relies on the silica-based drug delivery technology by DelSiTech Ltd. Our solution will free cat owners from stressful and sometimes unsuccessful administration of oral drug to their pet and ensure adequate pain management during the healing period.
We are now looking for an early-stage collaboration or licensing deal for this project. Results of the proof-of-concept are available by request.